Please join us for the Ninth Annual Fall Symposium & Luncheon "Hope on the Horizon." This event comprises a morning symposium with leading Alzheimer's researchers and a luncheon to present the Charles Evans Award. This year we will be honoring David R. Weinreb, Chief Executive Officer of The Howard Hughes Corporation.
The event will begin with a morning symposium "Biomarkers to Accelerate Drug Development for Alzheimer's Disease," moderated by Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF. Panelists include:
- Richard S. Isaacson, MD, Director, Alzheimer's Prevention Clinic, Weill Cornell Memory Disorders Program
- Michelle M. Mielke, PhD, Professor, Departments of Health Sciences Research & Neurology, Mayo Clinic
- Mark A. Mintun, MD, Vice President of Neuroscience, Eli Lilly & Co.
All proceeds from "Hope on the Horizon" support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer's and related diseases.
For more information, contact firstname.lastname@example.org.